Last reviewed · How we verify
Vernal conjunctivitis
Approved treatments
- Intal · Pfizer
- Cromoglicate · LEO Pharma
- Alomide · Novartis
- Cromoglycate · Vishwajit Nimgaonkar, MD PhD
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Vernal conjunctivitis patent landscape — cliff calendar, originator estates, attackable patents
- Vernal conjunctivitis treatment landscape brief
- Vernal conjunctivitis treatment updates RSS
Frequently asked questions about Vernal conjunctivitis
What drugs treat Vernal conjunctivitis?
Tracked treatments include Intal, Cromoglicate, Alomide, Cromoglycate.
What is the treatment for Vernal conjunctivitis?
Standard treatment for Vernal conjunctivitis includes Intal, Cromoglicate, Alomide, Cromoglycate. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Vernal conjunctivitis patent cliff · Vernal conjunctivitis CI report
- Treatment: Intal · Pfizer
- Treatment: Cromoglicate · LEO Pharma
- Treatment: Alomide · Novartis
- Treatment: Cromoglycate · Vishwajit Nimgaonkar, MD PhD
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing